EFIGALO

This brand name is authorized in Croatia, Estonia, Lithuania, Poland.

Active ingredients

The drug EFIGALO contains one active pharmaceutical ingredient (API):

1
UNII G926EC510T - FINGOLIMOD HYDROCHLORIDE
 

Fingolimod is a sphingosine 1-phosphate receptor modulator. Fingolimod is metabolised by sphingosine kinase to the active metabolite fingolimod phosphate. By acting as a functional antagonist of S1P receptors on lymphocytes, fingolimod phosphate blocks the capacity of lymphocytes to egress from lymph nodes, causing a redistribution, rather than depletion, of lymphocytes.

 
Read more about Fingolimod

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L04AE01 Fingolimod L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AE Sphingosine-1-phosphate (S1P) receptor modulators
Discover more medicines within L04AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1807039, 1807040, 1807051, 1807062, 1807073, 1807084, 1807095, 1807107, 1807118
HR Agencija za lijekove i medicinske proizvode HR-H-665003707
LT Valstybinė vaistų kontrolės tarnyba 1092182, 1092183, 1092184, 1092185, 1092186, 1092187, 1092188, 1092189, 1092190, 1092191, 1092192, 1092193, 1092194, 1092195, 1092196, 1092197, 1092198, 1092199, 1092200
PL Rejestru Produktów Leczniczych 100430163

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.